Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine

被引：0
|
作者：
Winner, Paul K. [1 ]
Bigal, Marcelo E. [2 ]
Aycardi, Ernesto [2 ]
Yeung, Paul P. [2 ]
Blankenbiller, Tricia [2 ]
Grozinski-Wolff, Melissa [2 ]
Yang, Ronghua [2 ]
Ma, Yuju [2 ]
机构：
[1] Palm Beach Headache Ctr, W Palm Beach, FL USA
[2] Teva Pharmaceut, Frazer, PA USA
来源：
NEUROLOGY | 2018年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P4.113
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Achievement of Response with Fremanezumab in the Treatment of Chronic Migraine
    Winner, P. K.
    Bigal, M.
    Aycardi, E.
    Yeung, P. P.
    Blankenbiller, T.
    Grozinski-Wolff, M.
    Yang, R.
    Ma, Y.
    HEADACHE, 2018, 58 : 78 - 79
  • [2] Achievement of Response over Time with Fremanezumab in the Treatment of Chronic and Episodic Migraine
    Silberstein, S. D.
    Lipton, R. B.
    Diamond, M. L.
    Cohen, J. M.
    Yang, R.
    Jiang, B.
    HEADACHE, 2018, 58 (08): : 1300 - 1301
  • [3] Achievement of response over time with fremanezumab in the treatment of chronic and episodic migraine
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diamond, Merle L.
    Cohen, Joshua M.
    Yang, Ronghua
    Jiang, Bo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [4] Fremanezumab for the Preventive Treatment of Chronic Migraine
    Silberstein, Stephen D.
    Dodick, David W.
    Bigal, Marcelo E.
    Yeung, Paul P.
    Goadsby, Peter J.
    Blankenbiller, Tricia
    Grozinski-Wolff, Melissa
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (22) : 2113 - 2122
  • [5] Fremanezumab as a preventive treatment for episodic and chronic migraine
    Bigal, Marcelo E.
    Walter, Sarah
    Rapoport, Alan M.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (08) : 719 - 728
  • [6] Achievement of response over time with fremanezumab in the treatment of chronic and episodic migraine (vol 19, pg P11, 2018)
    Silberstein, Stephen D.
    Lipton, Richard B.
    Diamond, Merle L.
    Cohen, Joshua M.
    Yang, Ronghua
    Jiang, Bo
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [7] Reductions in Migraine Frequency With Fremanezumab Treatment in Individuals With Chronic and Episodic Migraine
    Nahas, S. J.
    Ning, X.
    Cohen, J. M.
    Barash, S.
    Campos, V. Ramirez
    Silberstein, S. D.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1) : 114 - 114
  • [8] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Singh, Halker R. B.
    Cohen, J. M.
    Bibeau, K.
    Galic, M.
    Seminerio, M. J.
    Campos, Ramirez, V
    Ailani, J.
    HEADACHE, 2018, 58 : 70 - 71
  • [9] Reversion of Patients with Chronic Migraine to an Episodic Migraine Classification with Fremanezumab Treatment
    Cohen, Joshua M.
    Bibeau, Kristen
    Galic, Maja
    Seminerio, Michael J.
    Ramirez-Campos, Verena
    Singh, Rashmi B. Halker
    Ailani, Jessica
    ANNALS OF NEUROLOGY, 2018, 84 : S183 - S184
  • [10] Reductions in Migraine Frequency With Fremanezumab Treatment in Individuals With Chronic and Episodic Migraine
    Nahas, S. J.
    Ning, X.
    Cohen, J. M.
    Barash, S.
    Campos, V. Ramirez
    Silberstein, S. D.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 169 - 169
12345